Additionally, the role of IKKα in promoting breast cancer growth in the presence of anti-estrogen therapy via activation of the Notch pathway has been well studied and provides a mechanism for hormone therapy resistance in an NF-κB–independent manner49. Here, NFKB1 is linked to breast cancer.